Skip to main content



) --




) hit a new 52-week high Tuesday as it traded at $67 compared with its previous 52-Week high of $64.21. Humana is changing hands at $66.49 with 633,712 shares traded as of 9:41 a.m. ET. Average volume has been 1.7 million shares over the past 30 days.

Humana has a market cap of $10.3 billion and is part of the

health care

sector and

health services

TheStreet Recommends

industry. Shares are up 12.2% year to date as of the close of trading on Friday.

Humana Inc. offers various health and supplemental benefit plans in the United States. Its Government segment comprises beneficiaries of government benefit programs and operates in three lines of businesses: Medicare, Military, and Medicaid. The company has a P/E ratio of 9.5, above the average health services industry P/E ratio of 8.4 and below the S&P 500 P/E ratio of 23.2.

TheStreet Ratings rates Humana as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full

Humana Ratings Report


See all

52-week high stocks

or get investment ideas from our

investment research center